Publications by authors named "Amy Schade"

Claim this Profile
E
EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic Regulators.
Naiara Perurena, Marina Watanabe, Amy E Schade, William Brown, Elizabeth Y Luo

Cancer Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.
Patrick Loi, Amy E Schade, Carrie L Rodriguez, Anjana Krishnan, Naiara Perurena

Cancer Discov· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution.
Amy E Schade, Naiara Perurena, Yoona Yang, Carrie L Rodriguez, Anjana Krishnan

Nature· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer.
Francesca Nardi, Naiara Perurena, Amy E Schade, Ze-Hua Li, Kenneth Ngo

J Clin Invest· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crafting figures to describe cellular processes.
Szymon W Kmiecik, Qiaoni Shi, Ye-Guang Chen, Jannis Moormann, Tatjana M Hildebrandt, Amy Schade

Trends Biochem Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC.
Amy E Schade, Ryan Kuzmickas, Carrie L Rodriguez, Kaia Mattioli, Miriam Enos

PLoS Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coordinating gene expression during the cell cycle.
Martin Fischer, Amy E Schade, Timothy B Branigan, Gerd A Müller, James A DeCaprio

Trends Biochem Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity.
Timothy B Branigan, David Kozono, Amy E Schade, Peter Deraska, Hembly G Rivas

Cell Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells.
Jong Wook Kim, Christian Berrios, Miju Kim, Amy E Schade, Guillaume Adelmant

Elife· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.
Amy E Schade, Martin Fischer, James A DeCaprio

Nucleic Acids Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Amy E Schade, Matthew G Oser, Hilary E Nicholson, James A DeCaprio

Oncogene· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Creating a comprehensive training documentation program.
Stacy Pritt, Paula Samalonis, Lori Bindley, Amy Schade

Lab Anim (NY)· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
For want of some references..
Jerald Silverman, Stacy Pritt, Amy Schade, John W Merrill, Colleen Cody

Lab Anim (NY)· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis